Search Orphan Drug Designations and Approvals
-
Generic Name: | Nanvuranlat |
---|---|
Date Designated: | 04/19/2022 |
Orphan Designation: | Treatment of biliary tract cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
J-Pharma Co., Ltd. Leading Venture Plaza 1 75-1 Onocho Tsurumi, Yokohama, Kanagawa 230-0046 Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-